CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 62 filers reported holding CHEMBIO DIAGNOSTICS INC in Q3 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4 | -100.0% | 20,300 | -6.5% | 0.00% | – |
| Q3 2022 | $9,000 | -25.0% | 21,700 | +58.4% | 0.00% | – |
| Q1 2022 | $12,000 | -20.0% | 13,700 | +4.0% | 0.00% | – |
| Q4 2021 | $15,000 | -94.1% | 13,173 | -87.0% | 0.00% | – |
| Q3 2021 | $255,000 | +138.3% | 101,370 | +185.5% | 0.00% | – |
| Q2 2021 | $107,000 | +33.8% | 35,500 | +51.1% | 0.00% | – |
| Q1 2021 | $80,000 | -72.8% | 23,500 | -61.0% | 0.00% | – |
| Q4 2020 | $294,000 | +44.1% | 60,300 | +40.9% | 0.00% | – |
| Q3 2020 | $204,000 | +42.7% | 42,800 | -4.9% | 0.00% | – |
| Q2 2020 | $143,000 | – | 45,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 344,060 | $1,634,000 | 1.26% |
| Union Square Park Capital Management, LLC | 400,000 | $1,900,000 | 0.76% |
| P.A.W. CAPITAL CORP | 100,000 | $475,000 | 0.42% |
| PRECEPT MANAGEMENT LLC | 150,000 | $713,000 | 0.29% |
| Newbridge Financial Services Group, Inc. | 73,500 | $349,000 | 0.29% |
| SANDERS MORRIS HARRIS LLC | 183,584 | $990,000 | 0.22% |
| FRIESS ASSOCIATES LLC | 555,000 | $2,636,000 | 0.19% |
| PERRITT CAPITAL MANAGEMENT INC | 30,651 | $146,000 | 0.09% |
| Ikarian Capital, LLC | 219,109 | $1,041,000 | 0.05% |
| SEGALL BRYANT & HAMILL, LLC | 705,823 | $3,352,000 | 0.04% |